Fmoc-Cys((RS)-2,3-di(palmitoyloxy)-propyl)-OH |
| Catalog No.GA21553 |
Incorporation of Fmoc-Pam2Cys-OH yields more hydrophilic products than incorporation of Pam?Cys-OH (F-2630) due to the free amino group obtained after attachment and deprotection. Nevertheless, the H-Pam?-peptides show comparable adjuvant activity.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 210532-98-2
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Incorporation of Fmoc-Pam2Cys-OH yields more hydrophilic products than incorporation of PamCys-OH due to the free amino group obtained after attachment and deprotection. Nevertheless, the H-Pam-peptides show comparable adjuvant activity.
Average Rating: 5 (Based on Reviews and 14 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *